Paid Clinical Trials in Gilbert, AZ
As of August 2026, 141 paid clinical trials are recruiting in Gilbert, Arizona. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Gilbert offers studies at sites including Banner MD Anderson Cancer Center for conditions such as Breast Cancer, Heart Failure, Colorectal Cancer, Metastatic Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Gilbert
Trials by drug in Gilbert
Filter results
Newly added in Gilbert
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease
134 clinical trials
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Study of Dotinurad Versus Allopurinol in Participants With Gout
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013)
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community Setting
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Top Research Study Locations in Gilbert
Researchers run research studies in Gilbert, AZ at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Banner MD Anderson Cancer Center | Breast Cancer, Multiple Myeloma, Colorectal Neoplasms | 57 |
| Banner Health | Mesothelioma, NSCLC, Non Small Cell Lung Cancer | 6 |
| Ironwood Cancer & Research Centers | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Carcinoma, Non-Small-Cell Lung | 5 |
| Banner MD Anderson | Androgen Axis Suppression, Anemia, Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis | 4 |
| Arizona Center for Cancer Care - Gilbert | Head and Neck Squamous Cell Carcinoma, Stage I Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8, Stage II Head and Neck Cutaneous Squamous Cell Carcinoma AJCC v8 | 3 |
| Mercy Gilbert Medical Center | Cardiovascular Disease and Lipoprotein(a), Heart Failure, Obesity | 3 |
| OrthoArizona | Fracture, Shoulder, Osteoarthritis Shoulder, Rotator Cuff Syndrome of Shoulder and Allied Disorders | 3 |
| Arizona Arthritis & Rheumatology Associates (AARA) - Gilbert | Gout, Tophaceous Gout | 2 |
| Banner Gateway Medical Center | Breast Cancer, Breast Neoplasms, Urothelial Carcinoma | 2 |
| Banner Health - MD Anderson Cancer Center | ALK-Positive Large B-Cell Lymphoma, AML, Burkitt Lymphoma | 2 |
| Clinical Trial Site | Acute Hepatic Porphyria, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
| Dignity Health - Mercy Gilbert Medical Center | Cardiovascular Diseases, Coronary Artery Disease, In-Stent Restenosis | 2 |
| Lighthouse Psychiatry | Depression, Depression - Major Depressive Disorder, Depression Disorder | 2 |
| Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), Diabetes Mellitus, Type 2, Elevated Lp(a) | 2 |
| AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Gilbert | Overweight or Obesity, Psoriatic Arthritis | 1 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Arizona Arthritis & Rheumatology Associates | Active Rheumatoid Arthritis | 1 |
| Arizona Arthritis & Rheumatology Associates, P.C. - Gilbert | Radiographic Axial Spondyloarthritis | 1 |
| Arizona Arthritis and Rheumatology Associates - Gilbert - 3645 S Rome St | Sjögren's Syndrome | 1 |
| Arizona Centers of Digestive Health | Barrett Esophagus, Barretts Esophagus With Dysplasia, Esophageal Adenocarcinoma | 1 |
| Associated Retina Consultans | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| Associated Retina Consultants | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Associated Retina Consultants (01065) | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Associated Retina Consultants - Gilbert | Age-Related Macular Degeneration, Choroidal Neovascularization, Macular Degeneration | 1 |
| Avenzo Therapeutics Recruiting Site | Biliary Tract Cancer (BTC), Epithelial Tumor, Locally Advanced | 1 |
Active & Upcoming Studies in Gilbert (2026)
Recruiting trials in Gilbert grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (75 active studies)
- Preoperative Semaglutide Prior to Radical Prostatectomy · EARLY_Phase 1 · Banner Health
- DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma · Phase 1, Phase 2 · Diakonos Oncology Corporation
Cardiovascular (8 active studies)
Diabetes & metabolic (6 active studies)
- A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight · Phase 3 · Novo Nordisk A/S
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (5 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Neurology & pain (4 active studies)
- AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea · Phase 3 · Novo Nordisk A/S
- A Study to Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5) · Phase 3 · Bristol-Myers Squibb
Mental health & behavior (2 active studies)
- RE104 Safety and Efficacy Study in Generalized Anxiety Disorder · Phase 2 · Reunion Neuroscience Inc
- A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder · Phase 3 · Cybin IRL Limited
Pediatric (1 active study)
- Study of SGR-1505 in Mature B-Cell Neoplasms · Phase 1 · Schrödinger, Inc.
Common conditions studied in Gilbert
- Breast Cancer (6 active studies)
- Heart Failure (5 active studies)
- Colorectal Cancer (4 active studies)
- Metastatic Breast Cancer (4 active studies)
- NSCLC (4 active studies)
- Obesity (4 active studies)
Leading research sponsors in Gilbert
- AstraZeneca
- Eli Lilly and Company
- Merck Sharp & Dohme LLC
- Pfizer
- A2 Biotherapeutics Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Gilbert?
There are approximately 141 recruiting clinical trials in Gilbert, Arizona listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Gilbert pay participants?
Most recruiting trials in Gilbert compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Gilbert?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Gilbert?
The most common conditions under active study in Gilbert include Breast Cancer (6), Heart Failure (5), Colorectal Cancer (4), Metastatic Breast Cancer (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Gilbert?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Gilbert on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Gilbert?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Gilbert?
Recruiting research sites in Gilbert include Banner MD Anderson Cancer Center, Banner Health, Ironwood Cancer & Research Centers, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Gilbert right now?
The largest active categories in Gilbert are Cancer & tumors (75), Cardiovascular (8), Diabetes & metabolic (6). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.